

Translating Advanced Molecular Biology into Precision Medicine
Dedicated to developing innovative molecular diagnostic technologies, SCB-Tech leverages proprietary magnetic nanoparticles for unparalleled biomarker capture and early disease detection.






Scientific Leadership
Our team comprises highly trained researchers with extensive international experience, driving innovation in molecular biology and nanotechnology.
Dr. Li Wei
Dr. Chen Ling
Dr. Wang Hao
Postdoctoral research at Johns Hopkins University, specializing in epigenetic gene methylation and cancer biomarkers.
Principal Investigator experience at the University of Rochester, focused on exosome biology and precision diagnostics.
Advanced education from China Pharmaceutical University, with expertise in magnetic nanoparticle development and translational oncology.






Why Partner with SCB-Tech?
Proprietary MNP Technology
Our unique magnetic nanoparticle platform ensures superior binding and recovery of rare biomarkers from clinical samples.
Simultaneous Multi-Marker Capture
Isolate exosomes, DNA, RNA, lncRNA, fusion genes, and microRNA in one integrated, efficient workflow.
Exceptional Sensitivity & Recovery
Designed for prostate cancer research, our methods improve the detection of even the most challenging low-abundance biomarkers.
Ready to Advance Your Research?
Partner with SCB-Tech for innovative molecular biology products, precision diagnostics, and customized research services.
SCB-Tech
Proprietary magnetic nanoparticle platforms for simultaneous multi-marker capture.
EXPLORE
Home
Products
Technology
Services
Tutorials
About
SCIENTIFIC SUPPORT
Tanshulin@scb-tech.net
Huangpu District, Guangzhou, China
SCB-Tech Research Laboratory
© 2026 SCB-Tech-Proprietary magnetic nanoparticle technology for translational oncology.
PRECISION MOLECULAR DIAGNOSTICS
